Access to healthcare
The Role of Eosinophils in Our Immune System
When a person has a higher percentage of eosinophils without a known cause, they may have an eosinophilic disease.
GSK Hosts Second “Protecting Our Communities” LinkedIn Live Event: Addressing Disparities in Vaccination
Judy Stewart, SVP, Head of US Vaccines at GSK, hosted the second installment of “Protecting Our Communities,” a U.S. LinkedIn Live series.
GSK Hosts First “Protecting Our Communities” LinkedIn Live Series: Improving Vaccination Rates Post COVID-19
Judy Stewart, SVP, Head of US Vaccines at GSK, hosted the first installment of “Protecting Our Communities,” a U.S. LinkedIn Live series.
Fighting malaria in the lab and on the ground
Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.
Pricing our medicines to help ensure patient access
We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record.
Helping patients in need
Insurance coverage can be challenging, financial circumstances can change quickly, and sometimes patients need assistance paying for their prescription medications or vaccines.
Global mission, local impact
We often hear of humanitarian work in other parts of the world, but here in the United States there is real need as well. Around 47 million in the US live in poverty.
In Africa, markets matter for a healthy society
When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.